Phibro Animal Health Corp - Class A
Research Phibro Animal Health Corp - Class A (PAHC) on Bullrun: valuation model: 28.1% undervalued, market cap USD 1.29B, P/E 13.7, dividend yield 1.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPAHC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Valuation signal28.1% undervalued
- Market capUSD 1.29B
- P/E13.7
- Dividend yield1.5%
- Financial periodFY2025
- RevenueUSD 1.30B
- Revenue growth27.4%
- Net incomeUSD 48.26M
- Free cash flowUSD 41.83M
- Gross margin30.9%
Valuation Snapshot
Bullrun's latest valuation model marks Phibro Animal Health Corp - Class A as 28.1% undervalued; latest market cap is USD 1.29B; P/E is 13.7; dividend yield is 1.5%.
About Phibro Animal Health Corp - Class A
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Frequently asked questions
Is Phibro Animal Health Corp - Class A overvalued or undervalued?
Bullrun's valuation model currently marks Phibro Animal Health Corp - Class A as 28.1% undervalued.
What is Phibro Animal Health Corp - Class A's market cap?
Phibro Animal Health Corp - Class A's market capitalization is USD 1.29B.
What is Phibro Animal Health Corp - Class A's P/E ratio?
Phibro Animal Health Corp - Class A's price-to-earnings (P/E) ratio is 13.7.
Does Phibro Animal Health Corp - Class A pay a dividend?
Phibro Animal Health Corp - Class A has a dividend yield of 1.5%.
What does Phibro Animal Health Corp - Class A do?
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.